Markopoulos Jody
Known title: DirectorCIK: 0001854410
Associated companies
Transaction History
| MIR | ▲ Buy | Grant | 1,333 | $19K | 9/30/2026 | View on chart |
| MIR | ▲ Buy | Grant | 7,383 | $0 | 5/13/2026 | View on chart |
| MIR | ▲ Buy | Grant | 880 | $0 | 6/30/2025 | View on chart |
| MIR | ▲ Buy | Grant | 7,977 | $0 | 5/15/2025 | View on chart |
| MIR | ▲ Buy | Grant | 1,307 | $0 | 3/31/2025 | View on chart |
| MIR | ▲ Buy | Grant | 1,095 | $0 | 12/31/2024 | View on chart |
| MIR | ▲ Buy | Grant | 1,730 | $0 | 9/30/2024 | View on chart |
| MIR | ▲ Buy | Grant | 13,500 | $0 | 6/4/2024 | View on chart |
| MIR | ▲ Buy | Grant | 2,340 | $0 | 6/30/2023 | View on chart |
| MIR | ▲ Buy | Grant | 11,850 | $0 | 6/6/2023 | View on chart |
| MIR | ▲ Buy | Grant | 2,295 | $0 | 3/31/2023 | View on chart |
| MIR | ▲ Buy | Grant | 2,837 | $0 | 12/30/2022 | View on chart |
| MIR | ▲ Buy | Grant | 2,641 | $0 | 9/30/2022 | View on chart |
| MIR | ▲ Buy | Grant | 3,274 | $0 | 7/1/2022 | View on chart |
| MIR | ▲ Buy | Grant | 14,274 | $0 | 6/15/2022 | View on chart |
| MIR | ▲ Buy | Grant | 2,309 | $0 | 3/31/2022 | View on chart |
| MIR | ▲ Buy | Grant | 5,817 | $0 | 12/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Mirion Shares Rise Amid Nuclear Sector Momentum
Mirion Technologies stock has climbed recently, partly driven by broader optimism in the nuclear sector following TVA's first small modular reactor construction permit. Analysts currently hold an average price target of $24.00 for the shares. The company's valuation remains high relative to its earnings, with a trailing P/E of 164.6.
Mirion Shares Rise Amid Nuclear Sector Momentum. Mirion Technologies stock has climbed recently, partly driven by broader optimism in the nuclear sector following TVA's first small modular reactor construction permit. Analysts currently hold an average price target of $24.00 for the shares. The company's valuation remains high relative to its earnings, with a trailing P/E of 164.6.